The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The company will now explore a buyer for its manufacturing site and exit in due course
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Subscribe To Our Newsletter & Stay Updated
